Reduction of left ventricular spontaneous echo contrast in cardiomyopathy by acute inotropic intervention or...

Area of Science:

• Cardiology
• Echocardiography
• Heart Failure

Background:

• Advanced cardiomyopathy patients often exhibit left ventricular (LV) spontaneous echo contrast.
• This contrast is associated with an increased risk of LV thromboembolism.
• Current management strategies for thromboembolism prevention may have limitations.

Purpose of the Study:

• To investigate if improving LV systolic function can reduce or eliminate LV spontaneous echo contrast.
• To assess the potential of hemodynamic improvement as a method for preventing thromboembolism in advanced cardiomyopathy.
• To evaluate the efficacy of acute inotropic drug infusions or aggressive medical therapy.

Main Methods:

• Six patients with advanced cardiomyopathy and LV spontaneous echo contrast were included.
• Patients received acute inotropic drug infusions or aggressive medical therapy to enhance LV systolic function.
• A blinded, randomized assessment of pre- and post-therapy echocardiograms was performed using a 0-4 scoring system for spontaneous echo contrast.

Main Results:

• LV spontaneous echo contrast significantly decreased in all six patients after therapy (average score reduced from 2.94 to 1.25, p < 0.005).
• Improvement in LV systolic function was directly correlated with the reduction in spontaneous echo contrast.
• The study demonstrated a measurable impact of hemodynamic improvement on echocardiographic findings.

Conclusions:

• Improvement in LV systolic function can effectively reduce LV spontaneous echo contrast in patients with advanced cardiomyopathy.
• This approach may serve as an adjunct to anticoagulation or a substitute in cases where anticoagulation is contraindicated for preventing LV thromboembolism.
• Further prospective, long-term studies with larger patient cohorts are warranted to confirm these findings.